• Publications
  • Influence
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
BACKGROUND Osteopontin (OPN) and osteoprotegerin (OPG) have recently emerged as key factors in both vascular remodeling and development of atherosclerosis. Arterial stiffness has an independentExpand
Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Inflammatory process is essential for the initiation and progression of vascular remodeling, entailing degradation and reorganization of the extra-cellular matrix (ECM) scaffold of the vessel wall,Expand
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
OBJECTIVES Dual antiplatelet therapy with aspirin and a platelet P2Y12 ADP receptor antagonist is the cornerstone of treatment following percutaneous coronary intervention (PCI). Several clinical andExpand
Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease.
Coronary artery disease (CAD) is a leading cause of death inwestern world. Several cardiovascular risk factors such as age, gender, diabetes mellitus, hyperlipidemia, have been recognized and areExpand
Effects of Ω-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study.
BACKGROUND Smoking is associated with endothelial dysfunction and arterial stiffness. Supplementation of Ω-3 PUFAs is associated with better prognosis. Aim of this study was to evaluate the effectsExpand
Vitamin D3, D2 and arterial wall properties in coronary artery disease.
OBJECTIVES There are two major forms of vitamin D, vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). We studied the effect of the different vitamin D fractions (D3/D2) on arterial wallExpand
High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel.
BACKGROUND In the present study, we evaluated the association of platelet reactivity with vascular function in patients after percutaneous coronary intervention receiving clopidogrel treatment. Expand